Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of Evelyn D’An to its Board of ...
BioSpace Senior Editor Annalee Armstrong headed to the J.P. Morgan Healthcare Conference with a months-long story idea ...
2d
Newsable Asianet News on MSNQuantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The SurgeShares of Quantum BioPharma Ltd. slipped premarket Friday, but as of Thursday's close, the stock was on track for a ...
Quantum BioPharma Ltd (NASDAQ:QNTM) shares are rising Tuesday after the company announced positive clinical trial results for ...
J&J, AstraZeneca, Novo Nordisk and Roche are among the companies that might take a hit from the soon-to-be-enacted fees, ...
RedHill Biopharma Ltd (RDHL) reported its Q1 2022 earnings, revealing a decrease in net revenues to $18.2 million from $22.1 million in the previous quarter. Despite this, the company achieved a gross ...
Pharmacies play a key role in improving drug development and patient care, offering insights, clinical trial support and ...
SG Americas Securities LLC grew its stake in shares of Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 30.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned ...
Zenas BioPharma (ZBIO) announced its 2024 accomplishments, outlined its key business objectives for 2025 and announced preliminary unaudited ...
Zenas BioPharma, Inc.’s ZBIO share price has surged by 13.37%, which has investors questioning if this is right time to sell.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results